This inventor holds 7 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: Momenta Pharmaceuticals, Inc., Janssen Biotech, Inc.. Active years: 2019-2025.
Location History:
- Somerville, MA (US) (2019 - 2023)
- Cambridge, MA (US) (2024)
Company Filing History:
Years Active: 2019-2025
Title: Laura Rutitzky: Innovator in Engineered Therapeutics
Introduction
Laura Rutitzky is a prominent inventor based in Somerville, MA (US), known for her significant contributions to the field of engineered therapeutics. With a total of 7 patents to her name, she has made remarkable strides in developing methods that enhance immune responses to treat various diseases, including cancers and infections.
Latest Patents
Among her latest patents, Rutitzky has focused on methods related to engineered Fc constructs. These inventions involve biologically active Fc domain-containing therapeutic constructs designed to induce immune cell activation. Her work aims to improve treatment outcomes for patients suffering from serious health conditions. Additionally, she has developed compositions and methods related to engineered IgG Fc constructs, further advancing the field of immunotherapy.
Career Highlights
Throughout her career, Laura has worked with notable companies such as Momenta Pharmaceuticals, Inc. and Janssen Biotech, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the industry and contribute to groundbreaking research.
Collaborations
Laura has had the opportunity to work alongside talented individuals, including Carlos J Bosques and Jonathan C Lansing. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Laura Rutitzky's work in engineered therapeutics exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in the field, paving the way for future breakthroughs in treatment methodologies.